EDVA.US Endovia Health Sciences, Inc.

Healthcare Biotechnology USA Stocks
0.1830 USD
Close of Nov 14, 2026
0.1340 6.76
Market cap
USD 2.09M
P/E
-
P/B
0.59x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is EDVA.US undervalued?

Graham number

The Graham number of Endovia Health Sciences, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Endovia Health Sciences, Inc. fundamental analysis

No fundamental analysis for Endovia Health Sciences, Inc. yet.

Endovia Health Sciences, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Endovia Health Sciences, Inc.

Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America. Its product includes CannEpil a pharmaceutical-grade cannabinoid formulation comprising cannabidiol and tetrahydrocannabinol isolates in an oral liquid solution. Endovia Health Sciences, Inc. formerly known as Splash B…

Full company profile